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Autoclaved Tumor Bone for Reconstruction
An Alternative in Developing Countries
Mujahid Jamil Khattak, FCPS; Masood Umer, FCPS; Haroon-ur-Rasheed, FCPS; and
Mohammad Umar, FAAOS
The options for reconstruction after excision of skeletal tu-
mors include reimplanting the autoclaved tumor-bearing
bone. We asked whether such bone will survive and unite
with normal bone and whether the local tumor recurrence
rate increases after its use. We ascertained the functional
outcome (Musculoskeletal Tumor Society score) and compli-
cations in 19 patients. After wide excision, the bony segment
was autoclaved at 120° for 10 minutes and reimplanted at the
original defect with intramedullary nails and compression
plates. Twelve of our 19 patients were available for followup.
The autoclaved segment united with the normal bone in 11 of
the 12 patients. No patients had fracture or resorption of the
autoclaved segment. Two patients had local tumor recur-
rence in nearby soft tissues, apparently unrelated to the au-
toclaved bone. The mean functional score was 70%. Com-
plications included fatigue failure of the nail in one patient,
superficial infection in three patients, and deep infection in
two patients. Reconstruction with autoclaved tumor-bearing
bone is a simple and effective tool in limb salvage. This tech-
nique is a cost-effective alternative for developing countries
circumventing complications of prosthetic and allograft re-
construction.
Level of Evidence: Therapeutic study, Level IV (case series).
See the Guidelines for Authors for a complete description of
levels of evidence.
There has been an increasing trend toward limb-sparing
approaches rather than amputation in musculoskeletal tu-
mor surgery. Limb-sparing surgery is performed in 70% to
80% of patients, even patients with high-grade sarcomas.6
Improvements in imaging modalities such as computed
tomography (CT) and magnetic resonance imaging (MRI)
and advances in neoadjuvant and adjuvant chemotherapy
also have influenced the ratio of ablative and limb-salvage
procedures.
Reconstruction of large skeletal defects after wide-
margin excision of skeletal tumors is complicated and
challenging. There are several limb-salvage options. Total
joint replacement prostheses and modular tumor prosthe-
ses offer maintenance of motion and immediate functional
restoration. However, prosthetic survival decreases with
time, and prostheses are almost certain to fail in young
patients.12,27 Studies of large-tumor prostheses have re-
ported failure rates of 33%,19,39 60%,37 and 100%.26 The
failures occur from infection24 and late complications such
as implant breakage and aseptic loosening.8,38 In develop-
ing countries such as Pakistan, prosthetic reconstruction is
not practical because of the expense of primary prosthetic
surgery for tumors.
Reconstruction with structural allografts is another al-
ternative. Allograft reconstruction has a definite associated
risk of disease transmission (eg, human immunodeficiency
virus and hepatitis). Investigators have reported a 12% to
23% nonunion rate in allografts.2,20 The rate of fracture
and infection with structural allografts has been reported
as 16%,3,33 67%,17,34 and 12%.35 Services providing allo-
grafts require standardization of donor selection, screen-
ing, procurement, storage, and retrieval. Importantly, a
standardized bone bank needs a large budget, and in Pak-
istan, sociocultural reasons preclude wide use. Therefore,
we have used autoclaved bone as an alternative in limb-
salvage procedures.
We asked whether such autoclaved bone survives and
unites with the host bone and whether there is risk of local
tumor recurrence related to the reimplanted autoclaved
tumor-bearing bone. We evaluated the functional outcome
and complications associated with this technique of recon-
struction.
MATERIALS AND METHODS
We retrospectively reviewed 19 consecutive patients with dif-
ferent malignant bone tumors. All patients with malignant bone
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tumors requiring reconstruction for limb salvage and with pre-
served cortical structure of the involved bone were included.
Three patients with aggressive lytic lesions or with tumors in-
volving very long bony segments were excluded. One of
these patients had telangiectatic osteosarcoma and two had
Ewing’s sarcoma. Ten of the 19 patients were males and
nine were females. The mean age of the patients at the time of
surgery was 21 years (range, 7–59 years). Twelve of our 19
patients were available for followup. Three patients died from
systemic disease. Three patients were lost to followup in a
6-month to 8-month period, and one patient had an above-knee
amputation.
The mean followup was 49 months (range, 18–80 months).
Twelve patients had a pathologically confirmed diagnosis of
osteogenic sarcoma, three patients had Ewing’s sarcoma, two
patients had chondrosarcomas, one patient had metastatic renal
cell carcinoma, and one patient had nonHodgkin’s lymphoma.
All patients had preoperative pulmonary CT scans and bone scan
to determine the stage of disease. We used preoperative MRI to
define local staging according to the classifications described by
Enneking et al.16 Fourteen patients had Stage IIB disease, four
patients had Stage IIIB disease, and one patient had Stage IIA
disease (Table 1).
A wide surgical margin was achieved in all patients. Surgi-
cal margins were confirmed by frozen sections of bone
marrow taken from the osteotomy site and soft tissues. The
length of the resected bony specimens varied from 12 cm to
22 cm. After resection, the bone segment was denuded of all
the attached soft tissue, and the intramedullary canal was
reamed. The segment then was autoclaved at 120°C for
10 minutes. The specimen was washed with saline mixed
with antibiotics (first-generation cephalosporin and amino-
glycosides) and then fixed in the original defect by appropri-
ate implants. Intramedullary Küntscher nails and dynamic
compression plates were used across the osteotomy site for
axial and rotational stability (Fig 1). Thirteen patients had con-
current knee arthrodeses. To promote union at the osteotomy
site, fixation was supplemented by autogenous bone grafts in six
patients, screened allografts in six patients, and free vascularized
fibular grafts in three patients. Four patients did not have supple-
mental bone grafting. All patients with osteogenic sarcoma and
Ewing’s sarcoma received preoperative and postoperative che-
motherapy.
Patients were followed up to observe the progress of union at
the osteotomy site and to identify complications, including tumor
recurrence or infection. We used the functional evaluation
adopted by the Musculoskeletal Tumor Society (MSTS).15,16
The clinical scoring was obtained on a point-by-point basis for
every patient, including general and specific criteria of the ex-
tremity. Plain radiographs, CT scans, chest scans, and bone scans
were done at 6-month intervals to observe any local or distant
metastases. Criteria for radiographic union were trabecular con-
tinuity on at least three cortices at the graft-host bone (autoclave
bone) junction (Fig 1). At least three of the authors (MJK, MU,
HR, MU) reviewed the radiographic and clinical observations
together in the outpatient clinic at the final followup. The senior
surgeon (MU) was present on all occasions.
RESULTS
The survival of the autoclaved tumor-bearing bone was
100%. We observed no fractures and no resorption of the
autoclaved segments. The autoclaved bony segment united
with the normal bone in 11 of the 12 patients. The mean
time for complete union was 24.2 months (range, 20–28
months). The patient without union had the nonunion at
the distal osteotomy site. In that patient, the compression
plating was revised with supplemental autogenous bone
grafting at the distal osteotomy site.
Two patients with osteogenic sarcoma had local soft
tissue recurrences not spatially related to the autoclaved
bone. One of these patients was lost to followup after 3
months. The patient lived in a remote area and presented
later with a local recurrence treated elsewhere. A plain
radiograph showed the recurrence in the soft tissue near
the distal osteotomy site. We recommended a course of
evaluation and management but the patient did not follow
up. The other patient did not receive postoperative che-
motherapy and was lost to followup. After 3 years, the
patient presented with local soft tissue recurrence and mul-
tiple metastases to the lung and died. The recurrence was
near the proximal osteotomy site, but did not involve the
bone on MRI. Three other patients died from multiple
distant metastases with no evidence of local recurrence.
The average MSTS functional score was 21.08, repre-
senting 70% overall function (Table 1). Three patients had
superficial wound infections. Each patient required two
surgical débridements. Cultures from the tissues revealed
no growth. These patients received intravenous first-
generation cephalosporin and aminoglycosides for 2
weeks. Two patients had deep infections. One patient was
treated successfully with multiple débridements, intrave-
nous antibiotics, and a local rotational flap for skin cov-
erage. One patient needed an above-knee amputation be-
cause the limb could not be salvaged. Fatigue failure of the
intramedullary (IM) nail occurred in one patient, which
was used without compression plates (Fig 2). We did an
exchange nailing, and the osteotomy site eventually
healed.
DISCUSSION
Reconstruction after wide excision in skeletal tumors is
challenging. Prosthetic reconstruction is attractive, but
long-term results have not been successful in younger pa-
tients.14,21,28,40 Also, the expenses involved with pros-
thetic reconstruction preclude its use in many areas. Allo-
graft reconstruction is another alternative, but establishing
a standard bone bank requires financing not available in
Pakistan and many other countries. Socioreligious reasons
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preclude use of allograft in many of our patients. There-
fore, we have used autoclaved bone for reconstruc-
tion. This is a well-recognized reconstructive tech-
nique.1,4,10,18,24,48,49 In contrast to allografts, autoclaved
autografts conform to the defect and use the patients’ tis-
sue for reconstruction. This eliminates the need for bone
banking and the risk of disease transmission associated
with allografts.
Our study has some limitations. We have no histologic
evidence of union, and strong fibrous tissue interposition
between the bony segments can eliminate pain and simu-
late bony union. We also have no histologic evidence of
graft revascularization and long-term graft survival. Long-
term studies with advanced imaging techniques are re-
quired to answer these questions.
Union occurred in 11 of our 12 patients who were fol-
lowed up, a rate comparable to those in other series.4,9,42
The time for union was 24.2 months (range, 20–28
months). This long period delays rehabilitation and func-
tional restoration, which is much faster after prosthetic
reconstruction. The extended duration for healing of the
graft has been its greatest criticism. The inductive capacity
and the mechanical strength of bone are largely destroyed
after autoclaving.41,43,44 For the same reason, temperatures
Fig 1A–E. (A) An AP radiograph shows diaphyseal osteogenic sarcoma of the femur in a 21-year-old man. (B) A lateral
radiograph of the same patient shows posterior cortical erosion. (C) A postoperative radiograph taken immediately after wide-
margin excision is shown. The autoclaved segment was 12 cm long and was stabilized by an IM nail and compression plates. (D)
Oblique and (E) AP radiographs taken 1 year postoperatively show how the distal osteotomy site healed with progressive union
at the proximal osteotomy site. The proximal osteotomy site also healed after 8 months.
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and heating times are different between studies7 (Ta-
ble 2).
Healing of autoclaved bone segments seems to be a
function of mechanically optimized osteosynthesis and
supplementation by bone grafts. Harding22 suggested an
autoclaved bone segment acts as a foreign body. Histo-
logic observation 3 years after the procedure showed the
grafts were covered by fibrous tissue.22 In contrast, Wan-
gerin et al46 reported histologic incorporation with no in-
flammatory reaction and early bony remodeling of the
avascular autoclaved bone. We presumed the absence of
surrounding fibrous tissue to indicate the bone was not
considered a foreign body. Fibrous tissue also may form in
reaction to construct instability.
Postoperative chemotherapy also can contribute to de-
layed healing of the reimplanted segment. The effect of
chemotherapy on osseointegration is well documented.
Studies have indicated chemotherapeutic agents including
doxorubicin, cisplatin, and ifosfamide substantially affect
new bone formation.45,50
Experiments suggest supplementation with vascular-
ized fibular grafts, allogeneic bone matrix, and bone mar-
row increases the rate of incorporation and strength.5 We
also have used different supplementary bone grafts in most
of our patients.
Two of our patients had local recurrence unrelated to
autoclaved bone. We think the results are acceptable and
comparable to those in previously published reports (Table 3).
TABLE 1. Patient Demographics, Complications, and Results
Patient
Number
Age
(years)
Gender Diagnosis Stage Surgery
Length of
Augoclaved
Segment
Results
(Musculoskeletal
Tumor Society score)
1 11/F Osteogenic sarcoma
(femur)
IIB Wide-margin excision,
knee arthrodesis
18 cm 23/30
2 21/M Osteogenic sarcoma
(femur)
IIB Wide-margin excision 12 cm 22/30
3 7/M Ewing’s sarcoma (femur) IIB Wide-margin excision 15 cm 20/30
4 59/M NonHodgkin’s lymphoma
(femur)
III Wide-margin excision 12 cm 21/30
5 15/F Osteogenic sarcoma
(femur)
III Wide-margin excision,
knee arthrodesis
18 cm Died from systemic disease
6 15/F Osteogenic sarcoma
(tibia)
IIB Wide-margin excision,
knee arthrodesis
15 cm Died from systemic disease
7 23/M Osteogenic sarcoma
(femur)
IIB Wide-margin excision,
knee arthrodesis
20 cm 20/30
8 45/M Chondrosarcoma (femur) IIA Wide-margin excision 15 cm Deep infection leading to
amputation
9 15/M Osteogenic sarcoma
(humerus)
IIB Wide-margin excision 14 cm Lost to followup, had local
recurrence, died from
systemic disease
10 44/M Metastatic renal carcinoma
(femur)
III Wide-margin excision 16 cm Lost to followup
11 11/F Osteogenic sarcoma
(femur)
IIB Wide-margin excision,
knee arthrodesis
20 cm 23/30
12 17/F Osteogenic sarcoma
(femur)
IIB Wide-margin excision,
knee arthrodesis
18 cm 20/30
13 21/M Ewing’s sarcoma (femur) IIB Wide-margin excision,
knee arthrodesis
14 cm 20/30
14 17/M Chondrosarcoma (femur) IIB Wide-margin excision,
knee arthrodesis
31 cm 21/30
15 10/F Osteosarcoma (humerus) IIB Wide-margin excision 13 cm 22/30
16 17/M Osteosarcoma (tibia) IIB Wide-margin excision,
knee arthrodesis
22 cm 22/30
17 18/F Osteosarcoma (femur) IIB Wide-margin excision,
knee arthrodesis
12 cm Loss to followup (local
recurrence)
18 15/F Osteosarcoma (tibia) IIB Wide-margin excision,
knee arthrodesis
21 cm Died from systemic disease
19 15/F Ewing’s sarcoma (femur) IIB Wide-margin excision,
knee arthrodesis
14 cm 19/30
Disease staged according to classification system described by Enneking et al.16
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Fig 2A–F. (A) An AP radiograph of an 11-year-old girl shows osteogenic sarcoma of the left distal femur. (B) A lateral radiograph
shows the patient’s knee. The bony structure of the femur is nicely preserved, and can be used for reconstruction after auto-
claving. (C) A postoperative radiograph shows the autoclaved reimplanted segment after bone grafting and knee arthrodesis using
custom-made intramedullary K nails. (D) Anteroposterior and lateral radiographs of the knee and tibia show how three-point
fixation was achieved using long custom Kuntscher nails. (E) Anteroposterior and (F) lateral radiographs show the patient 2 years
postoperatively. Exchange nailing was done after 6 months because of fatigue failure. The radiographs show a healed and
consolidated autoclaved tumor-bearing bone at the proximal and distal osteotomy sites.
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The high infection rate in our patients was a concern,
but it could not be attributed solely to the reconstruction
technique. Bone tumor excision necessitates extensive soft
tissue resection to obtain tumor-free margins. Local clear-
ance of the tumor cannot be compromised. This affects the
blood supply of the surgically treated area, which makes it
vulnerable to infection. The amputation rates associated
with periprosthetic infection are even greater (40–
87%).25,47 Our infection rate was comparable with those of
other methods of reconstruction, including autografts and
allografts.11,13,30 We think careful surgical planning, me-
ticulous dissection, strict aseptic technique, and perioper-
ative antibiotic coverage can help reduce infection. In ad-
dition, if plastic and microvascular surgeons are involved
in the surgical planning, it could help to avoid ischemic
local skin flaps and dead space, minimizing the risk of
infection.
Unlike prosthetic reconstruction, this technique has not
always provided a mobile joint: 13 of our patients had
knee arthrodeses. However, the overall function of our
patients was 70%, which is acceptable and comparable to
function provided by other modes of reconstruction.12,14,20
Although arthrodesis is not a desirable result, stiff and
pain-free weightbearing limbs can serve most functions.
Our technique produced good results. Our patients are now
disease free with durable biologic reconstructions and ac-
ceptable functional outcomes.
We think reimplantation of tumor-bearing autoclaved
bone segments is a simple, cost-effective, and practical
reconstruction method in limb-salvage surgery. The auto-
claved segments take longer to heal but result in biologic
replacement of the resected segment, minimizing the
chances of revision surgery. Local tumor recurrence, com-
plication rate, and functional outcome of the technique are
acceptable. Using autoclaved bone segments is worth con-
sidering in developing countries where the resources for
tumor prostheses and bone banks are limited.31,32,36 All
established reconstruction methods are associated with
high complication rates, and new surgical options should
be explored.
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